Paul Scherz

Academic Area

  • Moral Theology/Ethics
  • School

  • School of Theology and Religious Studies
  • Expertise

  • Bioethics
  • Ethics and Practice
  • Michel Focault's Ethics
  • Religion and Science
  • Technology Ethics
  • Virtue ethics (focusing on Stoicism)
  • Biography

    Paul Scherz began his academic career researching the genetics of embryonic development. After completing a B.A. at U.C. Berkeley, a Ph.D. in Genetics at Harvard University, and a postdoctoral fellowship at UCSF, he decided to investigate the theological and ethical implications of biomedical research. He received an M.T.S. and a Ph.D. in Moral Theology from the University of Notre Dame. Dr. Scherz researches the moral theology of biotechnology and medical practice, with a focus on the role of the Stoic virtue tradition in Christian ethics. His book, Science and Christian Ethics, draws on his dual training to examine the moral formation of scientists, especially in the face of the reproducibility crisis in science.

    His most recent book, Tomorrow’s Troubles, and his ongoing research examines the role that quantitative risk analysis plays in contemporary practical reason and social practice in areas such as direct-to-consumer genetic testing, risk-reducing medications, the use of algorithms in social media, and contemporary governance. He compares these attempts to control future dangers with classical understandings of prudence and Christian calls to avoid excessive solicitude. He also studies end-of-life ethics, examining how concepts embedded in the ars moriendi tradition can inform contemporary aging and dying.


    • Tomorrow's Troubles: Risk, Anxiety, and Prudence in an Age of Algorithmic Governance

      Tomorrow's Troubles: Risk, Anxiety, and Prudence in an Age of Algorithmic Governance

      Learn More
    • Science and Christian Ethics

      Science and Christian Ethics

      Cambridge University Press, 2019

      Learn More
    • The Evening of Life

      The Evening of Life

      University of Notre Dame Press, 2020

      Learn More